← All stocks

ANGIODYNAMICS INC

ANGO Net selling
CIK 0001275187 #2891 in the set updated 20 Sep 2026
Bought (120 mo)
$1.89M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$143.31M
$0.00 on a plan · $1.37M straight out of an exercise
Sold at will
$141.94M
21 of 25 sales
Net
−$141.42M
−$140.06M against sales at will

By person

26 insiders · 68 transactions
15.8×

James C. Clemmer holds 15.8 times base salary in stock. $12.70M of shares against $803.03K in salary for 2025.

Salary from the company's own proxy. The shares are what James C. Clemmer last reported holding, valued at $14.72, the price Common Stock was last bought or sold at on the open market here, on 30 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Avista Capital Partners GP, LLC entity
10% owner
$70.39M (5)
−$70.39M
381,406
0.9228%
$5.61M
−92.7%
Burgstahler David F
Director
$70.39M (5)
−$70.39M
405,394
0.9808%
$5.97M
−92.3%
Clemmer James C
President and CEO
$1.61M (9)
+$1.61M
862,448
2.09%
$12.70M
+1,286%
Richard Stark
SVP, GM - Oncology
$446.49K (1) scheduled
−$446.49K
20,754
0.0502%
$305.50K
+12.6%
Helsel Dave
SVP Global Operations and R&D
$432.51K (5)
−$432.51K
28,289
0.0684%
$416.41K
+62.0%
Nighan Warren JR
SVP Quality and Regulatory
$5.29K (2)
$393.99K (2)
−$388.70K
64,745
0.1566%
$953.05K
+264.0%
Centea Scott
SVP/GM, VIT
$335.04K (1) scheduled
−$335.04K
58,128
0.1406%
$855.64K
+33.1%
JOHNSON WESLEY
Director
$293.28K (3)
−$293.28K
155,425
0.3760%
$2.29M
+299.8%
Gould Kevin J
Director
$292.79K (1) scheduled
−$292.79K
77,504
0.1875%
$1.14M
+141.5%
Campbell Chad Thomas
SVP/GM, Vascular Access
$291.81K (1) scheduled
−$291.81K
108,676
0.2629%
$1.60M
+527.2%
Weiss Lawrence T
SVP, Chief Legal Officer
$118.10K (1)
+$118.10K
91,330
0.2210%
$1.34M
DONNELLY HOWARD W
Director
$78.60K (1)
+$78.60K
178,938
0.4329%
$2.63M
+324.6%
Trowbridge Stephen A
EVP and CFO
$67.00K (5)
+$67.00K
305,796
0.7398%
$4.50M
+614.1%
Greiner Michael
EVP and CFO
$41.75K (1)
−$41.75K
33,438
0.0809%
$492.21K
+234.4%
REED JAN STERN
Director
$5.06K (1)
+$5.06K
116,921
0.2829%
$1.72M
Meteny Dennis S
Director
140,019
0.3388%
$2.06M
+132.6%
Auen Eileen O'Shea
Director
116,605
0.2821%
$1.72M
Licitra Karen A
Director
102,322
0.2476%
$1.51M
Tarnoff Michael E
Director
95,265
0.2305%
$1.40M
GOLD JEFFREY
Director
83,640
0.2024%
$1.23M
+60.7%
Piccinini Laura
SVP International
81,929
0.1982%
$1.21M
Burgess Lorinda
Director
67,144
0.1624%
$988.36K
LaPorte Steve
Director
48,484
0.1173%
$713.68K
+41.8%
ROSENZWEIG RICHARD C
SVP and General Counsel
15,730
0.0381%
$231.55K
Simpson Robert Arthur
SVP/GM, Global Vascular
15,441
0.0374%
$227.29K
Boucher Brent J.
SVP and GM of Oncology
15,416
0.0373%
$226.92K
+9.9%
Insider
Date
Role
Action
Shares
Price
Amount
Weiss Lawrence T
21 Oct 2025
SVP, Chief Legal Officer
Buy
10,000
$11.81
$118.10K
Trowbridge Stephen A
13 Oct 2025
EVP and CFO
Buy
890
$11.16
$9.93K
Clemmer James C
9 Oct 2025
President and CEO
Buy
10,000
$11.15
$111.50K
Nighan Warren JR
10 Oct 2024
SVP Quality and Regulatory
Buy
100
$6.08
$608.00
Trowbridge Stephen A
8 Oct 2024
EVP and CFO
Buy
1,700
$5.86
$9.96K
Clemmer James C
7 Oct 2024
President and CEO
Buy
20,000
$6.03
$120.60K
Nighan Warren JR
7 Oct 2024
SVP Quality and Regulatory
Buy
768
$6.09
$4.68K
Clemmer James C
8 Apr 2024
President and CEO
Buy
10,000
$6.70
$67.00K
Trowbridge Stephen A
12 Oct 2022
EVP and CFO
Buy
1,083
$13.82
$14.97K
Clemmer James C
10 Oct 2022
President and CEO
Buy
10,000
$15.00
$150.00K
Trowbridge Stephen A
12 Jan 2022
EVP and CFO
Buy
1,000
$22.64
$22.64K
Clemmer James C
11 Jan 2022
President and CEO
Buy
10,000
$22.84
$228.40K
Trowbridge Stephen A
11 Aug 2020
EVP and CFO
Buy
1,013
$9.38
$9.50K
Clemmer James C
31 Jul 2020
President and CEO
Buy
40,000
$8.26
$330.40K
Clemmer James C
25 Oct 2019
President and CEO
Buy
15,000
$14.19
$212.85K
REED JAN STERN
24 Jul 2017
Director
Buy
316
$16.00
$5.06K
Clemmer James C
21 Jul 2017
President and CEO
Buy
5,000
$15.79
$78.95K
DONNELLY HOWARD W
21 Jul 2017
Director
Buy
5,000
$15.72
$78.60K
Clemmer James C
20 Jul 2017
President and CEO
Buy
20,000
$15.64
$312.80K

What was left out

Form 4 filings counted 324
Amendments (4/A) skipped 16
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 4
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 4,497,404
Sales filed before the plan box existed 19
History held since 6 Sep 2016